This was also observed in ccRCC with both propranolol (p = 0.014) and ICI (p = 0.0028), at variance with the results published by Shepard et al. [36], in which VEGF levels remained unchanged after 200 μM of propranolol treatment. Here, VEGFA is linked to nonpapillary renal cell carcinoma.